Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.30 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7737845 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL61818 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL542776 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL77969 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL13858690 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL9956415 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL25327994 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL7340365 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL11594630 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 | |
| SCHEMBL625943 | 1.00 | KMT2A (0.36) | KMT2ANISCHCA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112824398-A | Immunomodulator | 成都先导药物开发股份有限公司 | 2021-05-21 | — | — | CN | disclosed |
| CN-112341450-A | Immunomodulator | 成都先导药物开发股份有限公司 | 2021-02-09 | — | — | CN | disclosed |
| WO-2010111737-A1 | PEPTIDE AND PHOSPHOPEPTIDE SYNTHESIS VIA PHOSPHATE ASSISTED LIGATION | THE UNIVERSITY OF SYDNEY (AU) | 2010-10-07 | — | — | WO | disclosed |
| US-6410748-B1 | Alicycli c group-containing monomer | KABUSHIKI KAISHA TOSHIBA (JP) | 2002-06-25 | — | — | US | disclosed |
| US-6291129-B1 | LIGHT SENSITIVE ELEMENT WITH UNSATURATED POLYMERS | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-09-18 | — | — | US | disclosed |
| US-5594025-A | Method of inhibiting gastric acid secretion with 5-substituted-3-aminochromane | ELI LILLY AND COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| US-5576352-A | Method of inhibiting gastric acid secretion with aryloxypropanolamines | ELI LILLY AND COMPANY (US) | 1996-11-19 | — | — | US | disclosed |
| US-5457120-A | Antisecretory and antiserotonine agents | ELI LILLY AND COMPANY (US) | 1995-10-10 | — | — | US | disclosed |
| US-5340838-A | Administering serotonin agonist to mammals | ELI LILLY AND COMPANY (US) | 1994-08-23 | — | — | US | disclosed |
| US-5258379-A | ADMINISTERING IN AN EFFECTIVE DOSAGE TO MAMMALS | ELI LILLY AND COMPANY (US) | 1993-11-02 | — | — | US | disclosed |
| US-5158956-A | Administering serotonin receptor agonist | ELI LILLY AND COMPANY (US) | 1992-10-27 | — | — | US | disclosed |